000			03288nam a22004455c 4500
999			_c7004 _d7004
001			7004
003			ES-MaUEC
005			20200702114225.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			181227s2019 gw a s |||| 0|eng d
020			_a9783030003623
024	7		_a10.1007/978-3-030-00362-3 _2doi
040			_bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC280 _b.A47 2019EB
245	0	0	_aAggressive Lymphomas _cedited by Georg Lenz, Gilles Salles.
264		1	_aCham _bSpringer International Publishing : _bImprint: Springer _c2019.
300			_aVII, 360 páginas 70 ilustraciones, 65 ilustraciones a color
336			_2rdacontent _aTexto (visual) _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF _2rda
490	1		_aHematologic Malignancies, _x2197-9766
490	0		_aMedicine (Springer-11650)
505	0		_aPART I: Epidemiology, Pathology and molecular Pathogenesis: Epidemiology -- Pathology and molecular pathogenesis of DLBCL and related entities -- Pathology and molecular pathogenesis of Burkitt lymphoma and lymphoblastic lymphoma -- Pathology and molecular pathogenesis of T-cell lymphoma -- Part III: Future directions in aggressive lymphomas: Role of modern imaging in aggressive lymphoma -- Kinase inhibitors -- Immunologic approaches -- Other novel targeted therapies -- How biology will help guiding our treatment decisions?.
520	3		_aThis book summarizes current knowledge of the biology and molecular pathogenesis of aggressive lymphomas and reviews the state of the art in diagnostic and therapeutic strategies. The aim is both to provide the reader with a sound understanding of the very significant progress that has been achieved in the understanding and management of these malignancies over recent years and to facilitate appropriate choice of the therapeutic strategy in individual cases. The assessment of different prognostic parameters are clearly presented in order to permits effective risk stratification that impacts on treatment choice. Recent insights into lymphomagenesis are exemplified and may assist in identifying emerging therapeutic targets. The comprehensive and up-to-date nature of the book will make it an ideal reference for all physicians and researchers interested in lymphoma, including clinicians from various medical specialties, biologists, pathologists, radiologists and nuclear medicine specialist, as well as students.
988			_aPrimersemestre_2019_Medicine
653		0	_aHematology.
653		0	_aPathology.
653		0	_aImmunology.
700	1		_aLenz, Georg. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aSalles, Gilles. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service) _9106937
776	0	8	_iPrinted edition: _z9783030003616
776	0	8	_iPrinted edition: _z9783030003630
830		0	_aHematologic Malignancies, _x2197-9766 _9133681
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-00362-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE
998			_db _feng _ggw _h0 _el